Australia's most trusted
source of pharma news
Friday, 12 December 2025
Friday, 12 December 2025
Subscribe
Login
No 1 pharma for customer experience
According to a new survey healthcare professionals are less pleased with the customer experience provided by pharma - but a few companies are bucking the trend.
Year ends with high-profile exits
Three senior staffers have announced their departure as 2025 draws to a close while others are taking fresh roles ahead of 2026
TODAY
AI analysis rescues trial efficacy
Aussie stroke drug with 'no efficacy' now shows 'significant efficacy' after AI was used to reanalyse trial info poorly judged by humans
TODAY
Pharma mood 'deeply pessimistic'
After a tough few years in pharma, the industry is overwhelmingly negative but maybe there's nowhere to go but up
11 December
Unprecedented pharma burnout
Smaller teams, heavy workloads and gruelling work hours are leaving almost no time for wellbeing, leading to burnout
10 December
Pharma boss wins business award
High-profile leader has been named Business Person of the Year for his strategic deal-making and willingness to take risks
10 December
Aussie jobs go in latest cost-cutting
Ongoing global belt-tightening at this Big Pharma has hit Australia with yet more jobs being lost from the ANZ sector
9 December
Latest Jobs
Senior Brand ManagerSite Medical DirectorSenior AccountantBusiness Analyst / Product Owner – Digital Health (EMR)4PL Logistics LeadResearch Governance OfficerMedical RepresentativeSenior Recruitment Consultant24 more...
Pharma in Focus Jobs
Marketing & Communications (3)
- Senior Brand Manager - Sydney
- Business Analyst / Product Owner – Digital Health (EMR) - Melbourne
- Senior Product Manager - Sydney
Sales & Customer Relations (11)
- Senior Accountant - Pymble
- Medical Representative - Sunshine Coast
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Devices Territory Manager - Brisbane
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
Clinical & Medical, R&D (9)
- Site Medical Director - Sydney
- Research Governance Officer - Camberwell
- Medical Representative - Sunshine Coast
- Medical Manager - Sydney
- Medical information and governance associate - Sydney
- Medical Sales Representative - Wollongong
- Clinical Research, Business Development Manager - China - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
Regulatory, Pharmacovigilance & QA (1)
Devices (1)
Executive Roles (4)
- Site Medical Director - Sydney
- Compliance & Legal Director - Macquarie Park
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
Other (12)
- 4PL Logistics Lead - North Sydney
- Senior Recruitment Consultant - Sydney
- Finance & Admin Officer - Macquarie Park
- Service Administrator - Belrose
- Freight & Distribution Specialist - Macquarie Park
- Warehouse Assistant - Rydalmere
- Technical Service & Warehouse Coordinator - Alexandria
- Finance Business Partner - Surry Hills
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
Big bash marks BMS milestone
Who's Who of industry, politics and patient advocacy attended an event in Melbourne last night to celebrate 70 years in Australia
11 December
$672M sale saga ends... maybe
While there's an official end to the gripping drama surrounding the failed sale of Aussie Mayne Pharma... the saga could roll on
11 December
Judge protects $74M J&J market
Generics company will need to clear the way before launching PBAC-recommended drug on the PBS
11 December
Pfizer unveils new obesity play
Hot on the heels of last month's drama-filled obesity buy, Pfizer has made another deal, this time for an oral GLP-1
11 December
Keys to building a great culture
There are three key features to developing a great culture where pharma professionals would love to work, industry exec tells
10 December
Aussies land $558M licensing deal
Indian generics giant has signed a deal with an Australian biotech as part of its plan to break into the innovative medicines market
10 December
Local coders drive JAK discovery
Aussie computational drug discovery company behind a targeted JAK inhibitor without the side effects of TGA-ticked meds
10 December
Top speed launch of first generic
From ARTG to pharmacy shelves in under a month, Arrotex has wasted no time launching generic competition to this GSK drug
9 December
Who's won an Aussie export gong?
Clinical trials company takes home its second prestigious award this year after rocketing sales in international markets
9 December
Vaccine probe uncovers flaws
Audit Office scrutinises Govt deals with Seqirus and Moderna, with one failing to maximise value for money for taxpayers
9 December
Data justifies hefty drug price tag
New data shows long-term durability of an expensive gene-therapy recently recommended for funding. Next, convince the Govt
9 December
Ex-Aussie GM writing tell-all book
Despite reaching career heights most pharma executives can only dream of, this boss offers a reality check about the meaning of success
8 December
Is ANZ Pharma ready for 2026?
Disruption across pharma will heighten in 2026. Are leaders ready? We're asking professionals from across the industry to take this survey
8 December
New data paves way for MSAC win
Pfizer announces impressive phase 3 results for its new haemophilia treatment which is under review by the MSAC
8 December